Evidence map›Paper›PMID 39611695›Full record

ArticleInfection and immunity2025

The ability of

Karen E Beenken, Mara J Campbell, Mark S Smeltzer

Abstract read
In one paragraph

Article in Infection and immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Osteomyelitis.Nature reviews. Disease primers · 2026
    Review
  2. Article
  3. Journal of bacteriology · 2026
    Article
  4. The secreted proteasesVirulence · 2025
    Article
  5. Article
  6. Antibiotics (Basel, Switzerland) · 2025
    Review
  7. Microorganisms · 2025
    Review
  8. Microorganisms · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Karen E BeenkenDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.ORCID 0000-0002-9152-8198
Mara J CampbellDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.ORCID 0000-0002-5131-8129
Mark S SmeltzerDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.ORCID 0000-0002-0878-0692

Funding

Pilot Grant ProgramP30GM145393 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI MARK S SMELTZER · 2022 to 2026
$7.6M
Impact of Staphylococcus aureus in osteomyelitis and bone physiologyR01AI119380 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI BEENKEN, KAREN E., SMELTZER, MARK S · 2015 to 2025
$4.1M
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) RO1AI119380-06HHS | NIH | National Institute of General Medical Sciences (NIGMS) P30-GM14593NIAID NIH HHS R01 AI119380NIGMS NIH HHS P30 GM145393Texas Hip and Knee Center
6 · The paper itself

Abstract

We demonstrate that mutation of the staphylococcal accessory regulator A (

Indexed as

Bacterial ProteinsOsteomyelitisPeptide HydrolasesStaphylococcal InfectionsStaphylococcus aureusTrans-ActivatorsAnimalsBiofilmsDisease Models, AnimalFemaleGene Expression Regulation, BacterialMiceMutationOsteoblastsVirulenceVirulence FactorsAgr protein, Staphylococcus aureusBacterial ProteinsPeptide HydrolasesSarA protein, Staphylococcus aureusTrans-ActivatorsVirulence FactorsagrosteomyelitispathogenesisproteasessarAStaphylococcus aureus

Identifiers

PMID39611695
PMCPMC11784413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.